Health Discoveries Corp. of Savannah,
Ga., has entered into a nonexclusive global licensing agreement with Bruker Daltonics
Inc. of Billerica, Mass. The agreement allows the latter company to combine its
mass-spectroscopy-based clinical proteomics product line, which enables biomarker
analysis, biofluid profiling, multivariate data analysis of large sample cohorts,
classical statistics and sample classification, with the Georgia company’s
Support Vector Machine pattern-recognition technology.
MORE FROM PHOTONICS MEDIA